Home/Veradermics/Reid Waldman, MD
RW

Reid Waldman, MD

Chief Executive Officer and Board Member

Veradermics

Therapeutic Areas

Veradermics Pipeline

DrugIndicationPhase
VDPHL01Pattern Hair Loss (Androgenetic Alopecia) in Males and FemalesPhase 3
Exploratory AssetAlopecia AreataExploratory/Pre-clinical